Faktor-Faktor yang Mempengaruhi Ketidakpatuhan Minum Obat pada Pasien Multidrug-Resistant Tuberculosis (MDR-TB): Systematic Review Studi Kohort dan Kasus Kontrol

Authors

  • Devina Aisha Salsabila Universitas Airlangga
  • Damba Bestari Universitas Airlangga
  • Ika Nindya Kadariswantiningsih Universitas Airlangga

DOI:

https://doi.org/10.55606/termometer.v4i3.6716

Keywords:

Case-Control Study, Cohort Study, Medication Non-Adherence, Multidrug-Resistant Tuberculosis, Systematic Review

Abstract

Multidrug-Resistant Tuberculosis (MDR-TB) is a global health challenge because its treatment involves a long duration and severe drug-related adverse effects. Medication non-adherence is one of the major factors contributing to treatment failure and the development of further drug resistance. This study aimed to analyze the factors influencing medication non-adherence among patients with MDR-TB through a synthesis of evidence from cohort and case-control studies. A systematic review was conducted based on the PRISMA guidelines, with literature searches performed in PubMed, ScienceDirect, ProQuest, and SINTA. The included studies were cohort and case-control studies published between 2020 and 2026. Analysis of five primary studies from Asia identified four major groups of factors contributing to non-adherence: clinical factors, sociodemographic and economic factors, psychosocial factors, and healthcare system factors. Clinical factors and severe drug-related adverse effects showed a strong association with non-adherence (pooled OR = 3.45; 95% CI: 2.10–5.67). Transportation costs, distance to healthcare facilities, low educational attainment, social stigma, inadequate family support, smoking, and alcohol consumption also increased the risk of non-adherence. Healthcare-related factors included the absence of active treatment supporters, suboptimal communication with healthcare providers, and treatment fatigue. Medication non-adherence among MDR-TB patients is multifactorial and requires integrated interventions, including adverse-effect management, transportation subsidies, strengthened family support, and optimization of treatment supporters to improve treatment success and retention.

Downloads

Download data is not yet available.

References

Baral, S. C., Aryal, Y., Bhattrai, R., King, R., & Newell, J. N. (2014). The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: Mixed method evidence from Nepal. BMC Public Health, 14(1), 1-10.

Caminero, J. A., Scardigli, A., & Piubello, A. (2015). Tuberculosis: Causes, treatment and non-adherence. The International Journal of Tuberculosis and Lung Disease, 19(8), 882-883.

Deshmukh, R. D., Dhande, D. J., Sachdeva, K. S., Sreenivas, A., Kumar, A. M. V., & Parmar, M. (2015). Patient and provider reported reasons for lost to follow up in MDR-TB treatment: A qualitative study from a drug resistant TB centre in India. PLoS One, 10(8), e0135802.

Kementerian Kesehatan Republik Indonesia. (2020). Pedoman nasional pelayanan kedokteran tata laksana tuberkulosis. Kementerian Kesehatan RI.

Loveday, M., Wallengren, K., Brust, J., Roberts, J., Voce, A., Margot, B., & Padayatchi, N. (2015). Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa. The International Journal of Tuberculosis and Lung Disease, 19(2), 163-171.

Makarim, & Lestari. (2023). Pengaruh stigma internal dan ketiadaan pendamping minum obat (PMO) aktif terhadap ketidakpatuhan pasien. Jurnal Epid Indo.

Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007). Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Medicine, 4(7), e238.

Nugroho, et al. (2025). Dampak kurangnya dukungan emosional keluarga dan ketidakpuasan komunikasi tenaga kesehatan terhadap pasien. Jurnal Medula.

O'Donnell, M. R., Wolf, A., Werner, L., Horsburgh, C. R., & Padayatchi, N. (2014). Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: A prospective cohort study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 67(1), 22-29.

Pradipta, et al. (2022). Hambatan ketiadaan tunjangan transportasi dan jarak fasilitas kesehatan pada pasien terapi DOTS. The Lancet Regional Health.

Ruru, Y., Matis, V. D., Lepia, A. F., Tarigan, R. V., Sarumpaet, S., & Iskandar, N. (2018). Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia. Global Health Action, 11(1), 1510592.

Sanchez-Padilla, E., Marquer, C., Kalon, S., Qiao, C., Raguenaud, M. E., & Wang, L. (2014). Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: A quantitative and qualitative study. The International Journal of Tuberculosis and Lung Disease, 18(2), 160-167.

Shringarpure, K. S., Isaakidis, P., Sagili, K. D., Baxi, R. K., Das, M., & Daftary, A. (2016). "When treatment is more challenging than the disease": A qualitative study of MDR-TB patients' perspectives on treatment in Gujarat, India. PLoS One, 11(3), e0150849.

Suryani, & Wijaya. (2024). Efek regimen OAT jangka panjang konvensional terhadap usia produktif muda. Jurnal Kesehatan Vok.

Toczek, A., Cox, H., du Cros, P., Cooke, G., & Ford, N. (2013). Strategies for reducing treatment default in drug-resistant tuberculosis: Systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease, 17(3), 299-307.

Tupasi, T. E., Garfin, A. M. C., Kurbatova, E. V., Mangan, J. M., Orillaza-Chi, R., Gler, M. T., & Golubkov, A. (2016). Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up. The International Journal of Tuberculosis and Lung Disease, 20(11), 1475-1481.

World Health Organization. (2022). WHO consolidated guidelines on tuberculosis: Module 4: Treatment - drug-resistant tuberculosis treatment. World Health Organization.

Yin, J., Yuan, J., Hu, Y., & Wei, X. (2016). Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: A systematic review and meta-analysis. PLoS One, 11(3), e0150511.

Zegeye, A., Dessie, G., Wagnew, F., Gebrie, A., Islam, S. M. S., Tesfaye, B., & Kiross, D. (2019). Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis. PLoS One, 14(1), e0210422.

Zhang, et al. (2024). Hubungan efek samping nefrotoksik berat dan tingkat literasi kesehatan rendah terhadap putus pengobatan. International Journal of Infectious Diseases.

Downloads

Published

2026-07-31

How to Cite

Devina Aisha Salsabila, Damba Bestari, & Ika Nindya Kadariswantiningsih. (2026). Faktor-Faktor yang Mempengaruhi Ketidakpatuhan Minum Obat pada Pasien Multidrug-Resistant Tuberculosis (MDR-TB): Systematic Review Studi Kohort dan Kasus Kontrol . Termometer: Jurnal Ilmiah Ilmu Kesehatan Dan Kedokteran, 4(3), 209–217. https://doi.org/10.55606/termometer.v4i3.6716

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.